Missouri Memory Center at Citizens Memorial Hospital participated in the Eli Lilly and Company international clinical trial of Donanemab, whose full results were shared Monday, July 17, at the 2023 Alzheimer's Association International Conference (AAIC) in Amsterdam, Netherlands, and simultaneously published in the Journal of the American Medical Association (JAMA).
This item is available in full to subscribers.
To continue reading, you will need to either log in to your subscriber account, or purchase a new subscription.
If you are a current print subscriber, you can set up a free website account and connect your subscription to it by clicking here.
If you are a digital subscriber with an active, online-only subscription then you already have an account here. Just reset your password if you've not yet logged in to your account on this new site.
Otherwise, click here to view your options for subscribing.
Please log in to continue
|
